Transom Capital Adds Dana Goldstein to Lead Investor Relations and Marketing
20. November 2024 09:00 ET
|
Transom Capital Group
LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Transom Capital Group (“Transom”) has named Dana Goldstein to the newly created position of Head of Investor Relations and Marketing, where she will...
FactSet and Irwin Announce Partnership to Deliver Best-in-Class Solution for Investor Relations Professionals
27. September 2023 08:00 ET
|
FactSet Research Systems Inc.
FactSet and Irwin announced a strategic partnership integrating Irwin’s award-winning investor relations CRM with FactSet’s Workstation.
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
11. September 2023 08:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
CENTOGENE to Present at the H.C. Wainwright Global Investment Conference
19. Mai 2022 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and...
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
01. Februar 2022 05:30 ET
|
Centogene NV
Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globallyEUR 15 million private placement from leading growth investors and a...
CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO
20. Dezember 2021 08:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
CENTOGENE Reports Second Quarter 2021 Financial Results
07. September 2021 06:35 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years
22. Juni 2021 06:30 ET
|
CENTOGENE GmbH
Company outlines significant value creation potential to contribute to the diagnosis of rare diseases and to enable the development of novel therapeuticsFocuses on leveraging its unique rare...
CENTOGENE to Announce Q1 2021 Financial Results on June 16, 2021
09. Juni 2021 16:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 09, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
CENTOGENE Announces Virtual Investor Event
07. Juni 2021 06:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 07, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...